Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.
from Reuters: Top News https://ift.tt/3b78Moo
via
IFTTT
0 comments: